| 1.09 0 (0%) | 10-03 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.35 | 1-year : | 1.57 |
| Resists | First : | 1.16 | Second : | 1.35 |
| Pivot price | 1.09 |
|||
| Supports | First : | 0.86 | Second : | 0.71 |
| MAs | MA(5) : | 1.09 |
MA(20) : | 1.07 |
| MA(100) : | 1.11 |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 33 |
D(3) : | 40.4 |
| RSI | RSI(14): 45.5 | |||
| 52-week | High : | 1200 | Low : | 0.55 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PLRZ ] has closed above bottom band by 49.1%. Bollinger Bands are 99.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 86 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.1 - 1.11 | 1.11 - 1.11 |
| Low: | 1.05 - 1.06 | 1.06 - 1.06 |
| Close: | 1.08 - 1.09 | 1.09 - 1.1 |
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.
Fri, 12 Sep 2025
60% Nasal Protection: Polyrizon's New Allergy Blocker Shows Promise in $210M Growing Market - Stock Titan
Thu, 14 Aug 2025
Polyrizon regains compliance with Nasdaq listing requirements - Investing.com
Thu, 31 Jul 2025
Polyrizon Ltd. Announces Special General Meeting for September 2025 - TipRanks
Tue, 22 Jul 2025
Polyrizon stock soars after promising nasal allergy blocker test results - Investing.com
Tue, 15 Jul 2025
Polyrizon Wins Crucial Nasdaq Appeal: Inside the $15.7M Biotech's Path to Compliance - Stock Titan
Tue, 15 Jul 2025
Polyrizon secures continued Nasdaq listing after panel hearing - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 6 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 6.1 (%) |
| Shares Short | 755 (K) |
| Shares Short P.Month | 360 (K) |
| EPS | -0.21 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.11 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -22.3 % |
| Return on Equity (ttm) | -12.2 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.53 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -3 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -5.46 |
| PEG Ratio | 0 |
| Price to Book value | 0.34 |
| Price to Sales | 0 |
| Price to Cash Flow | -2.49 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|